diethylnitrosamine has been researched along with (2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, M; Ishibashi, N; Kagawa, M; Kohno, H; Moriwaki, H; Okuno, M; Sano, T; Suzuki, R; Tanaka, T | 1 |
| Iwasa, J; Kubota, M; Moriwaki, H; Sakai, H; Shimizu, M; Shirakami, Y; Takai, K; Tanaka, T; Tsurumi, H; Yasuda, Y | 1 |
| Fukaya, Y; Ishibashi, N; Kojima, S; Moriwaki, H; Okuno, M; Sano, T; Tatsukawa, H; Watanabe, M | 1 |
| Hitomi, K; Ishibashi, N; Kojima, S; Moriwaki, H; Qin, XY; Shimizu, M; Shirakami, Y; Tatsukawa, H | 1 |
| Funaki, M; Honda, M; Kaneko, S; Kitabayashi, J; Murai, K; Nagata, N; Okada, H; Ota, T; Oyama, T; Sakai, Y; Shimakami, T; Shirasaki, T; Takegoshi, K; Takuwa, Y; Yamashita, T | 1 |
| Aihara, Y; Kaji, K; Kawaratani, H; Kitade, M; Mitoro, A; Moriya, K; Namisaki, T; Nishimura, N; Okura, Y; Sato, S; Sawada, Y; Seki, K; Takaya, H; Yoshiji, H | 1 |
6 other study(ies) available for diethylnitrosamine and (2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid
| Article | Year |
|---|---|
An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation.
Topics: Animals; Anticarcinogenic Agents; Cell Division; Diethylnitrosamine; Dose-Response Relationship, Drug; Immunohistochemistry; Liver Neoplasms, Experimental; Male; Rats; Rats, Inbred F344; Retinoids; Transforming Growth Factor alpha | 2004 |
Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cytokines; Diabetes Complications; Diabetes Mellitus; Diethylnitrosamine; Insulin Resistance; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Phosphorylation; ras Proteins; Receptors, Leptin; Retinoid X Receptor alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; STAT3 Transcription Factor; Tretinoin | 2011 |
Dual induction of caspase 3- and transglutaminase-dependent apoptosis by acyclic retinoid in hepatocellular carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Diethylnitrosamine; Down-Regulation; ErbB Receptors; Gene Knockdown Techniques; GTP-Binding Proteins; Humans; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Protein Glutamine gamma Glutamyltransferase 2; Rats; Retinoid X Receptor alpha; Sp1 Transcription Factor; Transglutaminases; Tretinoin; Tumor Cells, Cultured; Up-Regulation | 2011 |
Metabolome Analyses Uncovered a Novel Inhibitory Effect of Acyclic Retinoid on Aberrant Lipogenesis in a Mouse Diethylnitrosamine-Induced Hepatic Tumorigenesis Model.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Blotting, Western; Carcinogenesis; Carcinoma, Hepatocellular; Chromatography, Liquid; Diethylnitrosamine; Lipogenesis; Liver Neoplasms, Experimental; Male; Metabolome; Metabolomics; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Real-Time Polymerase Chain Reaction; Receptors, Leptin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tretinoin; Tumor Cells, Cultured | 2016 |
Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Diethylnitrosamine; Gene Expression Regulation, Enzymologic; Hepatitis C; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Neoplasms, Experimental; Mice, Knockout; Mice, Transgenic; Phosphotransferases (Alcohol Group Acceptor); Retinoids; Sphingolipids | 2017 |
Acyclic retinoid and angiotensin-II receptor blocker exert a combined protective effect against diethylnitrosamine-induced hepatocarcinogenesis in diabetic OLETF rats.
Topics: Angiotensin Receptor Antagonists; Animals; Biomarkers; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Diethylnitrosamine; Disease Models, Animal; DNA Damage; Drug Synergism; Humans; Lipid Peroxidation; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Oxidative Stress; Protective Agents; Rats; Rats, Inbred OLETF; Tretinoin | 2018 |